OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA (CML) IN THE EARLY IMATINIB MESYLATE (IM) ERA

被引：0
|
作者：
Khoury, H. J. [1 ]
Kukreja, M. [1 ]
Wang, T. [1 ]
Woolfrey, A. [1 ]
Szer, J. [1 ]
Cortes, J. [1 ]
Horowitz, M. M. [1 ]
Lee, S. [1 ]
机构：
[1] CIBMTR, Milwaukee, WI USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.178
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
151
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [21] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN THE ERA OF IMATINIB - A SINGLE CENTER EXPERIENCE
    Constanco, M.
    Vaz, C.
    Ferreira, R.
    Campilho, F.
    Rosales, M.
    Roncon, S.
    Campos, A., Jr.
    HAEMATOLOGICA, 2013, 98 : 653 - 654
  • [22] Imatinib (Glivec) therapy in advanced chronic myeloid leukemia (CML) patients in combination with allogeneic peripheral blood stem cell transplantation (PBSCT).
    le Coutre, P
    Massenkeil, G
    Zschieschang, P
    Genvresse, I
    Schwarz, M
    Reich, G
    Körner, H
    Dörken, B
    Arnold, R
    BLOOD, 2002, 100 (11) : 428A - 429A
  • [23] Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: A preliminary assessment
    Simon, William
    Segel, George B.
    Lichtman, Marshall A.
    BLOOD CELLS MOLECULES AND DISEASES, 2006, 37 (02) : 116 - 124
  • [24] Survival Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) and Imatinib in the Treatment of Chronic Myeloid Leukemia Treatment in China: a Meta-Analysis
    Huang, Xiaojun
    Shen, Zhixiang
    Chen, Zi
    Cao, Yang
    Xu, Xiaoping
    Wang, Qiang
    de Costa, Samara Mendes
    Dummett, Henry
    Chen, Jie
    BLOOD, 2009, 114 (22) : 985 - 985
  • [25] Allogeneic stem cell transplantation for advanced phase chronic myeloid leukaemia: experience from the imatinib era
    Holroyd, A.
    Pearce, R.
    Latif, A. L.
    Byrne, J.
    Roomallah, B.
    Clark, R. E.
    Marks, D. I.
    Shaw, B.
    Cook, G.
    Apperley, J. F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S126 - S126
  • [26] Allogeneic Stem Cell Transplantation In Chronic Myeloid Leukemia In TKIs Era
    Ahmed, Parvez
    Mahmood, Syed Karman
    Satti, Tariq Mahmood
    Chaudhry, Qamar Un Nisa
    Shahbaz, Nighat
    Khan, Mehreen Ali
    Satti, Humayoon Shafique
    BLOOD, 2013, 122 (21)
  • [27] Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation
    Olavarria, E
    Craddock, C
    Dazzi, F
    Marin, D
    Marktel, S
    Apperley, JF
    Goldman, JM
    BLOOD, 2002, 99 (10) : 3861 - 3862
  • [28] First successful allogeneic hematopoietic stem cell transplantation in children with chronic myeloid leukemia, preceded by imatinib prior transplantation
    Wu, Kang-Hsi
    Weng, Te-Fu
    Chen, Ming-Chieh
    Peng, Ching-Tien
    BLOOD, 2007, 110 (11) : 213B - 213B
  • [29] The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia
    Oehler, Vivian G.
    Gooley, Ted
    Snyder, David S.
    Johnston, Laura
    Lin, Allen
    Cummings, Carrie C.
    Chu, Su
    Bhatia, Ravi
    Forman, Stephen J.
    Negrin, Robert S.
    Appelbaum, Frederick R.
    Radich, Jerald P.
    BLOOD, 2007, 109 (04) : 1782 - 1789
  • [30] Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era
    Champlin, Richard
    de Lima, Marcos
    Kebriaei, Partow
    Rondon, Gabriela
    Fisher, Tobi
    Jabbour, Elias
    Cortes, Jorge E.
    Kantarjian, Hagop
    Anderlini, Paolo
    Alousi, Amin
    Hosing, Chitra
    Shpall, Elizabeth
    Popat, Uday
    Qazilbash, Muzaffar
    Andersson, Borje
    Giralt, Sergio
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S261 - S265
12345